Challenging Conventional Practices: Opioid Usage in Moderate Sedation

The dental sedation field has witnessed an alarming increase in patient morbidity and mortality. Research has identified the primary cause of sedation-related deaths to be the unforeseen effects of anesthetics. Consequently, dental practitioners must understand these medications thoroughly and consider alternative approaches.

Levels of Sedation

There are four recognized levels of sedation: minimal sedation, moderate sedation, deep sedation, and general anesthesia.

Minimal sedation is a drug-induced state in which patients are awake and respond normally to verbal commands. While individuals under minimal sedation may experience decreased cognition and coordination, they can still maintain their airways, and their cardiovascular functions are unaffected.

Moderate sedation is a deeper level of sedation where patients are highly relaxed yet still awake and responsive. This is also considered safe as patients can maintain their respiratory and cardiovascular functions.

Deep sedation is a state induced by drugs where the patient only responds purposefully to repeated or painful stimuli.

General anesthesia renders the patient unresponsive even to acute pain. Both deep sedation and general anesthesia pose risks as patients may struggle to maintain an open airway independently.

Sedation levels are not fixed, meaning a patient can transition from a less sedated state to a more sedated state or vice versa. Some dental providers may unintentionally allow patients to slip into deeper sedation levels without realizing it. Since sedation exists on a continuum, dentists must be able to recognize and differentiate these levels, taking necessary steps to safely return patients to an appropriate level if they exceed their intended state.

Factors Affecting Sedation

Sedation providers must consider factors such as age, weight, medications, allergies, organ function, and comorbidities when administering sedation medication. Opioid administration can affect respiratory function differently depending on these factors and can inhibit chemoreceptors which help regulate breathing resulting in respiratory depression.

Opioid Receptors and Opioids

Morphine, while highly effective for sedation and pain relief, has undesirable side effects. Its slow onset and long duration can lead to over sedation and respiratory depression if additional doses are given too soon. Patients receiving morphine in outpatient may experience lingering sedation and respiratory depression after leaving. Furthermore, morphine can trigger histamine release, worsening conditions in patients with obstructive lung diseases.

Meperidine may be used for sedation in pediatric patients and those with special needs. It has a faster onset and shorter duration compared to morphine. However, like morphine, it can cause severe respiratory depression and histamine release leading to low blood pressure and bronchospasm. Additionally, meperidine can result in rapid heart rate, biliary spasms, and urinary retention. It also can have fatal interactions with certain medications.

Fentanyl, a synthetic opioid, is significantly more potent than morphine. Dosing fentanyl in the same way as morphine can lead to an overdose. It is favoured for sedation due to its quick onset of action and short duration, making it safer for outpatient procedures. However, fentanyl has serious side effects. Rapid administration can cause life-threatening chest wall rigidity and severe bradycardia. Most importantly, combining it with other drugs can intensify these effects.

Metabolizing Opioids

Most drugs, including opioids, are metabolized in the liver, yet some, like fentanyl and meperidine, are metabolized by the CYP3A4 enzyme. Commonly prescribed medications like antibiotics can inhibit CYP3A4 causing a buildup of these opioids in the blood, leading to intensified side effects.

Reversing Opioids

Naloxone, an opioid antagonist, reverses analgesia, sedation, bradycardia, and respiratory depression caused by opioids. However, naloxone’s short half-life of 60 minutes means that patients may still experience opioid effects after. Some patients may become re-sedated and experience respiratory depression once naloxone wears off. Naloxone administration also has undesirable side effects, including tachyarrhythmias, hypertension, acute algesia, and pulmonary edema.

Alternatives and Other Considerations

Opioids interact with multiple drugs, which causes respiratory depression. Fentanyl and meperidine are lipophilic amines that bind to lung tissue. Typically, a significant portion of fentanyl is attached to lung tissues, but when another lipophilic amine like propranolol is present, the binding rate decreases, leading to a potentially fatal overdose. Patients taking propranolol or with special needs should avoid sedation with fentanyl or meperidine. As a result, dental practitioners should explore alternatives like nitrous oxide or benzodiazepines first for minimal and moderate sedation.